Bristol Takes $455 Mil. Litigation Charge, Higher Than Earlier Expectations
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb increased its litigation reserves to $455 mil. in the second quarter, a charge that is $55 mil. higher than earlier expectations